Stockholders' Equity Note Disclosure [Text Block] | Note 11 – Stockholders’ Equity Settlement of Lawsuit On April 25, 2014, the Company reached an agreement with the former owner of Turf Chemistry, Inc., Alfredo Ledesma. As part of the settlement agreement 400,000 shares of the Company’s restricted common stock were issued. Shares Issued to Officers and Employee On September 1, 2015, the Company granted 5,000,000 shares of restricted stock to an employee as part of his employment agreement and recorded $10,000 of stock compensation. On August 15, 2014, the Company granted 28,000,000 shares of restricted stock to David Dugas, Chief Executive Officer and 28,000,000 shares of restricted stock to Tony Primeaux Vice President for their provision of personal guarantees on the Transfac Financing Agreement. Common Stock Issued for Services On August 15, 2014, the Company issued 6,000,000 shares of its common stock to a vendor for services rendered. The shares were valued at $60,000 and recorded as stock based compensation. On September 2, 2014, the Company issued 9,500,000 shares of its common stock to a vendor for services rendered. The shares were valued at $95,000 and recorded as stock based compensation. On December 31, 2014, the Company issued 200,000 shares of its common stock to a lease holder for services rendered. The shares were valued at $2,000 and recorded as stock based compensation. Shares Issued for Forbearance Agreement On September 2, 2014, the Company issued 9,500,000 shares of its common stock to a vendor under a forbearance agreement. The shares were valued at $95,000 and recorded as stock based compensation. Warrants Issued The following table reflects a summary of common stock warrants outstanding and warrant activity during the periods: Number of warrants Weighted Average Exercise Price Weighted (Years) Warrants outstanding at December 31, 2013 63,092,278 $ 0.16 2.21 Granted during the period - - - Exercised during period - - - Forfeited during the period (2,205,238 ) (0.09 ) - Warrants outstanding at December 31, 2014 60,887,040 $ 0.16 0.67 Granted during the period - - - Exercised during period - - - Forfeited during the period (42,455,667 ) (0.20 ) - Warrants outstanding at September 30, 2015 18,431,373 $ 0.09 .16 The Common Stock warrants expire in years ended September 30 as follows: Year Amount 2015 666,667 2016 1,000,000 2017 11,764,706 2018 5,000,000 Total 18,431,373 Stock Option Awards During the periods ended September 30, 2015 and September 30, 2014 the Company did not grant any stock options. On July 29, 2011, shareholders approved the 2011 Stock Option and Incentive Plan, which authorized up to 5,000,000 options shares. Under the plan the exercise price per share for the stock covered by a stock option granted pursuant shall not be less than 100% of the fair market value on the date of grant. In the case of an incentive stock option that is granted to a 10% owner, the option price of such incentive stock option shall be not less than 110% of the Fair Market Value on the grant date. The term of each stock option shall be fixed but no stock option shall be exercisable more than ten years after the date the stock option is granted. In the case of an incentive stock option that is granted to a ten percent owner, the term of such stock option shall be no more than five years from the date of grant. Stock option activity summary covering options is presented in the table below: Number of Shares Weighted- average Exercise Price Weighted- average Remaining Contractual Term (years) Outstanding at December 31, 2013 52,930,000 0.12 7.9 Granted - - - Exercised - - - Expired/Forfeited (35,000 ) (0.14 ) 6.6 Outstanding at December 31, 2014 52,895,000 $ 0.12 6.9 Granted - - - Exercised - - - Expired/Forfeited (432,000 ) (0.14 ) - Outstanding at September 30, 2015 52,463,000 $ 0.12 6.2 Exercisable at September 30, 2015 49,663,000 $ 0.12 6.2 Exercisable at December 31, 2014 50,095,000 $ 0.12 6.9 A summary of the Company’s non-vested options at September 30, 2015, and changes during the nine months ended September 30, 2015, is presented below: Options Weighted Non-vested, beginning of period 2,800,000 $ 0.12 Granted - $ - Vested - $ - Forfeited - $ - Non-vested, end of period 2,800,000 $ 0.12 The following tables summarize information about stock options outstanding and exercisable at September 30, 2015: Options Outstanding at September 30, 2015 Range of Exercise Prices Number Outstanding Weighted Remaining Contractual Life (years) Weighted Average Exercise Price Aggregate Intrinsic Value(1) $0.09 to $0.10 28,250,000 7.0 $ 0.10 $ - $0.11 to $0.12 2,000,000 6.0 $ 0.12 $ - $0.13 to $0.15 22,645,000 5.3 $ 0.15 $ - $0.09 to $0.15 52,895,000 6.2 $ 0.12 $ - Options Exercisable at September 30, 2015 Range of Exercise Prices Number Exercisable Weighted Remaining Contractual Life (years) Weighted Average Exercise Price Aggregate Intrinsic Value(1) $0.09 to $0.10 25,450,000 7.0 $ 0.09 $ - $0.11 to $0.12 2,000,000 6.0 $ 0.12 $ - $0.13 to $0.15 22,213,000 5.3 $ 0.15 $ - $0.09 to $0.15 49,663,000 6.2 $ 0.12 $ - (1) The aggregate intrinsic value in the table represents the difference between the closing stock price on September 30, 2015 and the exercise price, multiplied by the number of in-the-money options that would have been received by the option holders had all option holders exercised their options on September 30, 2015. No options were exercised during the nine month period ended September 30, 2015. During the nine months ended September 30, 2015, the Company recognized stock-based compensation expense of $205,972 related to stock options. As of September 30, 2015, there was approximately $478,352 of total unrecognized compensation cost related to non-vested stock options, which is expected to be recognized over the remaining vesting period. During the nine months ended September 30, 2014, the Company recognized stock-based compensation expense of $527,752 related to stock options. As of September 30, 2014, there was approximately $862,252 of total unrecognized compensation cost related to non-vested stock options, which is expected to be recognized over the remaining vesting period. The aggregate intrinsic value of these options was $0 at September 30, 2014. |